JP7874887B2 - Gaba-aポジティブアロステリック調節物質のヘミ-クエン酸塩およびその結晶形態 - Google Patents
Gaba-aポジティブアロステリック調節物質のヘミ-クエン酸塩およびその結晶形態Info
- Publication number
- JP7874887B2 JP7874887B2 JP2023549823A JP2023549823A JP7874887B2 JP 7874887 B2 JP7874887 B2 JP 7874887B2 JP 2023549823 A JP2023549823 A JP 2023549823A JP 2023549823 A JP2023549823 A JP 2023549823A JP 7874887 B2 JP7874887 B2 JP 7874887B2
- Authority
- JP
- Japan
- Prior art keywords
- citrate
- compound
- weight
- hemi
- hemy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/265—Citric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyridine Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026025898A JP2026097871A (ja) | 2021-02-18 | 2026-02-20 | Gaba-aポジティブアロステリック調節物質のヘミ-クエン酸塩およびその結晶形態 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163150782P | 2021-02-18 | 2021-02-18 | |
| US63/150,782 | 2021-02-18 | ||
| PCT/US2022/016612 WO2022178000A1 (en) | 2021-02-18 | 2022-02-16 | Hemi-citrate salts of gaba-a positive allosteric modulator and crystalline form thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026025898A Division JP2026097871A (ja) | 2021-02-18 | 2026-02-20 | Gaba-aポジティブアロステリック調節物質のヘミ-クエン酸塩およびその結晶形態 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024506942A JP2024506942A (ja) | 2024-02-15 |
| JP2024506942A5 JP2024506942A5 (cg-RX-API-DMAC10.html) | 2025-02-25 |
| JP7874887B2 true JP7874887B2 (ja) | 2026-06-17 |
Family
ID=82931143
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023549823A Active JP7874887B2 (ja) | 2021-02-18 | 2022-02-16 | Gaba-aポジティブアロステリック調節物質のヘミ-クエン酸塩およびその結晶形態 |
| JP2026025898A Pending JP2026097871A (ja) | 2021-02-18 | 2026-02-20 | Gaba-aポジティブアロステリック調節物質のヘミ-クエン酸塩およびその結晶形態 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026025898A Pending JP2026097871A (ja) | 2021-02-18 | 2026-02-20 | Gaba-aポジティブアロステリック調節物質のヘミ-クエン酸塩およびその結晶形態 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20240190910A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4294819A4 (cg-RX-API-DMAC10.html) |
| JP (2) | JP7874887B2 (cg-RX-API-DMAC10.html) |
| TW (1) | TW202245790A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022178000A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10562930B1 (en) | 2018-08-31 | 2020-02-18 | Praxis Precision Medicines, Inc. | Salts and crystal forms of GABAA positive allosteric modulator |
| EP4514357A4 (en) * | 2022-04-26 | 2026-04-29 | Praxis Prec Medicines Inc | METHODS OF TREATING NEUROLOGICAL DISORDERS |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021504297A (ja) | 2018-08-31 | 2021-02-15 | プラクシス プレシジョン メディスンズ,インコーポレイテッドPraxis Precision Medicines,Inc. | Gabaaの正のアロステリックモジュレーターの塩及び結晶形態 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004072079A1 (en) * | 2003-02-11 | 2004-08-26 | Pfizer Limited | Hydrated and anhydrous sildenafil hemi-citrate compound |
| US20060074059A1 (en) * | 2004-08-26 | 2006-04-06 | Goliber Philip A | Isomorphic crystalline habits of 3alpha-hydroxy-21-(1'-imidazolyl)-3beta-methoxymethyl-5alpha-pregnane-20-one |
| DK2168585T3 (da) * | 2005-06-09 | 2012-02-27 | Euro Celtique Sa | Farmaceutiske sammensætninger af en neuroaktiv steroid og anvendelser deraf |
-
2022
- 2022-02-16 WO PCT/US2022/016612 patent/WO2022178000A1/en not_active Ceased
- 2022-02-16 JP JP2023549823A patent/JP7874887B2/ja active Active
- 2022-02-16 EP EP22756844.1A patent/EP4294819A4/en active Pending
- 2022-02-16 US US18/546,800 patent/US20240190910A1/en active Pending
- 2022-02-17 TW TW111105875A patent/TW202245790A/zh unknown
- 2022-05-25 US US17/824,205 patent/US11697669B2/en active Active
-
2026
- 2026-02-20 JP JP2026025898A patent/JP2026097871A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021504297A (ja) | 2018-08-31 | 2021-02-15 | プラクシス プレシジョン メディスンズ,インコーポレイテッドPraxis Precision Medicines,Inc. | Gabaaの正のアロステリックモジュレーターの塩及び結晶形態 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20220289789A1 (en) | 2022-09-15 |
| US11697669B2 (en) | 2023-07-11 |
| TW202245790A (zh) | 2022-12-01 |
| US20240190910A1 (en) | 2024-06-13 |
| EP4294819A4 (en) | 2024-12-18 |
| JP2026097871A (ja) | 2026-06-16 |
| WO2022178000A1 (en) | 2022-08-25 |
| EP4294819A1 (en) | 2023-12-27 |
| JP2024506942A (ja) | 2024-02-15 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250214 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250214 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250527 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250818 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20251028 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260220 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20260519 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20260529 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7874887 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |